Skip to content

13F-HR filed by FCPM III SERVICES B.V.

FCPM III SERVICES B.V. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 8 holding rows worth $592,382,325.

Accession
0000950123-25-002356
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 12 entries on the cover page, a total value of $592,382,325 stated on the cover page (in dollars after the unit check, H1), rows summing to $592,382,325 with VALUE read as dollars as filed, 13F file number 028-24008. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerForbion Growth Management B.V. 028-24009
  • included managerForbion IV Management B.V. 028-24010
  • included managerForbion Growth Management II B.V.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK10,597,181$272,347,552dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock5,462,846$128,704,652dollars as filed
ENGENE HOLDINGS INC29286M105COM9,632,561$64,056,530dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS3,452,330$48,332,620dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK3,970,668$48,084,789dollars as filed
ASTRIA THERAPEUTICS INC COM04635X102Stock2,872,537$25,680,481dollars as filed
ACHILLES THERAPEUTICS PL-ADR00449L102COM2,390,050$2,748,558dollars as filed
ENGENE HOLDINGS INC29286M113W EXP 10/31/20282,878,148$2,427,143dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-002356this filing2025-02-14acceptance time not in the bulk data set